Filed: Jul. 16, 2018
Latest Update: Jul. 16, 2018
Summary: ORDER ROBERT F. KELLY , District Judge . AND NOW , this 16th day of July, 2018, upon consideration of the Motion to Remand filed by Plaintiffs, the City of New Castle, City of Aliquippa, and Union Township (Doc. No. 9), Defendants, Teva Pharmaceuticals USA, Inc. and Cephalon, Inc.'s (collectively, "Teva Defendants") Response in Opposition to Plaintiffs' Motion to Remand, which included the argument that the Court should stay this action pending the transfer of the action to the federal mul
Summary: ORDER ROBERT F. KELLY , District Judge . AND NOW , this 16th day of July, 2018, upon consideration of the Motion to Remand filed by Plaintiffs, the City of New Castle, City of Aliquippa, and Union Township (Doc. No. 9), Defendants, Teva Pharmaceuticals USA, Inc. and Cephalon, Inc.'s (collectively, "Teva Defendants") Response in Opposition to Plaintiffs' Motion to Remand, which included the argument that the Court should stay this action pending the transfer of the action to the federal mult..
More
ORDER
ROBERT F. KELLY, District Judge.
AND NOW, this 16th day of July, 2018, upon consideration of the Motion to Remand filed by Plaintiffs, the City of New Castle, City of Aliquippa, and Union Township (Doc. No. 9), Defendants, Teva Pharmaceuticals USA, Inc. and Cephalon, Inc.'s (collectively, "Teva Defendants") Response in Opposition to Plaintiffs' Motion to Remand, which included the argument that the Court should stay this action pending the transfer of the action to the federal multidistrict litigation ("MDL") entitled In re Nat'l Prescription Opiate Litig., MDL No. 2804 ("Opiate MDL"), and Plaintiffs' Reply, it is hereby ORDERED that:
1. Plaintiffs' Motion to Remand is DENIED WITHOUT PREJUDICE;
2. Teva Defendants' request for a stay is GRANTED; and
3. all proceedings are STAYED pending the Judicial Panel on Multidistrict Litigation's ("JPML") decision as to whether to transfer this case to the Opiate MDL. The parties shall submit a joint status report within fourteen (14) days of receiving a decision from the JPML.
